These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 25006537)
1. Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia. Xu L; Xu Y; Jing Z; Wang X; Zha X; Zeng C; Chen S; Yang L; Luo G; Li B; Li Y Exp Hematol Oncol; 2014; 3():17. PubMed ID: 25006537 [TBL] [Abstract][Full Text] [Related]
2. Discovery and functional implications of a miR-29b-1/miR-29a cluster polymorphism in acute myeloid leukemia. Ngankeu A; Ranganathan P; Havelange V; Nicolet D; Volinia S; Powell BL; Kolitz JE; Uy GL; Stone RM; Kornblau SM; Andreeff M; Croce CM; Bloomfield CD; Garzon R Oncotarget; 2018 Jan; 9(4):4354-4365. PubMed ID: 29435107 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the Diagnostic Potential of miR-29a-3p and miR-92a-3p as Circulatory Biomarkers in Acute Myeloid Leukemia. Gado MM; Mousa NO; Badawy MA; El Taweel MA; Osman A Asian Pac J Cancer Prev; 2019 Dec; 20(12):3625-3633. PubMed ID: 31870103 [TBL] [Abstract][Full Text] [Related]
4. The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia. Gong JN; Yu J; Lin HS; Zhang XH; Yin XL; Xiao Z; Wang F; Wang XS; Su R; Shen C; Zhao HL; Ma YN; Zhang JW Cell Death Differ; 2014 Jan; 21(1):100-12. PubMed ID: 24076586 [TBL] [Abstract][Full Text] [Related]
5. An AML1-ETO/miR-29b-1 regulatory circuit modulates phenotypic properties of acute myeloid leukemia cells. Zaidi SK; Perez AW; White ES; Lian JB; Stein JL; Stein GS Oncotarget; 2017 Jun; 8(25):39994-40005. PubMed ID: 28611288 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of miR-29a expression in pediatric acute myeloid leukemia. Zhu C; Wang Y; Kuai W; Sun X; Chen H; Hong Z Clin Biochem; 2013 Jan; 46(1-2):49-53. PubMed ID: 22981932 [TBL] [Abstract][Full Text] [Related]
8. Role of microRNA-29b in myelodysplastic syndromes during transformation to overt leukaemia. Kirimura S; Kurata M; Nakagawa Y; Onishi I; Abe-Suzuki S; Abe S; Yamamoto K; Kitagawa M Pathology; 2016 Apr; 48(3):233-41. PubMed ID: 27020498 [TBL] [Abstract][Full Text] [Related]
9. MiR-29a promotes intestinal epithelial apoptosis in ulcerative colitis by down-regulating Mcl-1. Lv B; Liu Z; Wang S; Liu F; Yang X; Hou J; Hou Z; Chen B Int J Clin Exp Pathol; 2014; 7(12):8542-52. PubMed ID: 25674218 [TBL] [Abstract][Full Text] [Related]
10. Expression of PVT-1 and miR-29a/29b as reliable biomarkers for liver cirrhosis and their correlation with the inflammatory biomarkers profile. Khalaf SE; Abdelfattah SN; Khaliefa AK; Daoud SA; Yahia E; Hasona NA Hum Exp Toxicol; 2024; 43():9603271241251451. PubMed ID: 38685136 [TBL] [Abstract][Full Text] [Related]
11. Circulating miRNA29 family expression levels in patients with essential hypertension as potential markers for left ventricular hypertrophy. Huang Y; Tang S; Huang C; Chen J; Li J; Cai A; Feng Y Clin Exp Hypertens; 2017; 39(2):119-125. PubMed ID: 28287884 [TBL] [Abstract][Full Text] [Related]
12. Silencing long non-coding RNA XIST suppresses drug resistance in acute myeloid leukemia through down-regulation of MYC by elevating microRNA-29a expression. Wang C; Li L; Li M; Wang W; Liu Y; Wang S Mol Med; 2020 Nov; 26(1):114. PubMed ID: 33228517 [TBL] [Abstract][Full Text] [Related]
13. MCL-1 is modulated in Crohn's disease fibrosis by miR-29b via IL-6 and IL-8. Nijhuis A; Curciarello R; Mehta S; Feakins R; Bishop CL; Lindsay JO; Silver A Cell Tissue Res; 2017 May; 368(2):325-335. PubMed ID: 28190086 [TBL] [Abstract][Full Text] [Related]
14. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias. Wang Y; Li Z; He C; Wang D; Yuan X; Chen J; Jin J Blood Cells Mol Dis; 2010 Mar; 44(3):191-7. PubMed ID: 20110180 [TBL] [Abstract][Full Text] [Related]
15. miR-29a and miR-142-3p downregulation and diagnostic implication in human acute myeloid leukemia. Wang F; Wang XS; Yang GH; Zhai PF; Xiao Z; Xia LY; Chen LR; Wang Y; Wang XZ; Bi LX; Liu N; Yu Y; Gao D; Huang BT; Wang J; Zhou DB; Gong JN; Zhao HL; Bi XH; Yu J; Zhang JW Mol Biol Rep; 2012 Mar; 39(3):2713-22. PubMed ID: 21678057 [TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia. Huang X; Schwind S; Yu B; Santhanam R; Wang H; Hoellerbauer P; Mims A; Klisovic R; Walker AR; Chan KK; Blum W; Perrotti D; Byrd JC; Bloomfield CD; Caligiuri MA; Lee RJ; Garzon R; Muthusamy N; Lee LJ; Marcucci G Clin Cancer Res; 2013 May; 19(9):2355-67. PubMed ID: 23493348 [TBL] [Abstract][Full Text] [Related]
17. miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction. Gigante M; Pontrelli P; Herr W; Gigante M; D'Avenia M; Zaza G; Cavalcanti E; Accetturo M; Lucarelli G; Carrieri G; Battaglia M; Storkus WJ; Gesualdo L; Ranieri E J Transl Med; 2016 Apr; 14():84. PubMed ID: 27063186 [TBL] [Abstract][Full Text] [Related]
18. The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML. Eyholzer M; Schmid S; Wilkens L; Mueller BU; Pabst T Br J Cancer; 2010 Jul; 103(2):275-84. PubMed ID: 20628397 [TBL] [Abstract][Full Text] [Related]
19. MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression. Desjobert C; Renalier MH; Bergalet J; Dejean E; Joseph N; Kruczynski A; Soulier J; Espinos E; Meggetto F; Cavaillé J; Delsol G; Lamant L Blood; 2011 Jun; 117(24):6627-37. PubMed ID: 21471522 [TBL] [Abstract][Full Text] [Related]
20. Combinatorial effects of miR-20a and miR-29b on neuronal apoptosis induced by spinal cord injury. Liu XJ; Zheng XP; Zhang R; Guo YL; Wang JH Int J Clin Exp Pathol; 2015; 8(4):3811-8. PubMed ID: 26097563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]